Madras Medical College develops 2 potential Anti-TB drugs, a
Two drug formulations developed in Madras Medical College have shown promise to effectively control tuberculosis bacteria in Petri dishes in laboratory conditions. Patents have been filed for the two novel synthetic molecules developed by the College of Pharmacy, Madras Medical College principal A Jerad Suresh said.

India accounts for one-fourth of the global TB incidence. In 2015, an estimated 28 lakh cases occurred and 4.8 lakh people died due to TB. “We hope the new formulations will be more effective than the existing combination. But it has to undergo several phases of trials, including ones on animal and humans, before it can be used on patients. If that happens, it may lead to solutions for drug-resistant strains of TB,” he said, refusing to give more details about the molecules.

As a broader step, the college has decided to apply to the Central Drugs Standard Control Organisation (CDSCO) seeking permission for mass production of drugs, particularly the antimicrobial solutions it has been producing on campus.

With an estimated saving of more than Rs 32.08 lakh per year for just one hospital, the college has convinced the state health department that it will be able to help all government hospitals to substantially cut down on the cost of hand sanitizers. “We are strengthening our infrastructure and human resources for mass production.

Read more:
D●●●a G●●●●●i and 61 others like this17 shares
Dr. P●●●●●●●a B●●●●●●●●●●a
Dr. P●●●●●●●a B●●●●●●●●●●a Other
Apr 16, 2019Like
S●●●●m S●●●●a
S●●●●m S●●●●a Psychiatry
Apr 16, 2019Like
Dr. DR H●●. C●●●●●●●●●●I H●●●●●I
Dr. DR H●●. C●●●●●●●●●●I H●●●●●I Internal Medicine
A boom for TB patients
Apr 19, 2019Like